341 related articles for article (PubMed ID: 33624520)
1. COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women.
Mortazavi S
AJR Am J Roentgenol; 2021 Oct; 217(4):857-858. PubMed ID: 33624520
[TBL] [Abstract][Full Text] [Related]
2. Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of COVID-19 Vaccination.
Edmonds CE; Zuckerman SP; Conant EF
AJR Am J Roentgenol; 2021 Oct; 217(4):831-834. PubMed ID: 33543649
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination.
Robinson KA; Maimone S; Gococo-Benore DA; Li Z; Advani PP; Chumsri S
JAMA Oncol; 2021 Sep; 7(9):1395-1397. PubMed ID: 34292295
[TBL] [Abstract][Full Text] [Related]
4. Mitigating the Impact of Coronavirus Disease (COVID-19) Vaccinations on Patients Undergoing Breast Imaging Examinations: A Pragmatic Approach.
Lehman CD; Lamb LR; D'Alessandro HA
AJR Am J Roentgenol; 2021 Sep; 217(3):584-586. PubMed ID: 33617288
[TBL] [Abstract][Full Text] [Related]
5. Adenopathy Following COVID-19 Vaccination.
Washington T; Bryan R; Clemow C
Radiology; 2021 Jun; 299(3):E280-E281. PubMed ID: 33625299
[No Abstract] [Full Text] [Related]
6. Axillary adenopathy detected on breast MRI following COVID-19 vaccination: outcomes and follow-up recommendations.
Nguyen DL; Chen X; Kwak L; Oluyemi ET; Mullen LA; Ambinder EB
Clin Imaging; 2023 Jan; 93():1-3. PubMed ID: 36335676
[TBL] [Abstract][Full Text] [Related]
7. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
8. Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines.
Brown A; Shah S; Dluzewski S; Musaddaq B; Wagner T; Szyszko T; Wan S; Groves A; Mokbel K; Malhotra A
Clin Radiol; 2021 Aug; 76(8):553-558. PubMed ID: 34053731
[TBL] [Abstract][Full Text] [Related]
9. Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma.
Ashoor A; Shephard J; Lissidini G; Nicosia L
Korean J Radiol; 2022 Jul; 23(7):775-776. PubMed ID: 35695318
[No Abstract] [Full Text] [Related]
10. Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.
Özütemiz C; Krystosek LA; Church AL; Chauhan A; Ellermann JM; Domingo-Musibay E; Steinberger D
Radiology; 2021 Jul; 300(1):E296-E300. PubMed ID: 33625300
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Vaccine-Related Axillary Adenopathy on Breast Imaging: Follow-Up Recommendations and Histopathologic Findings.
Nguyen DL; Ambinder EB; Myers KS; Mullen LA; Panigrahi B; Oluyemi E
AJR Am J Roentgenol; 2022 Jun; 218(6):997-998. PubMed ID: 34935404
[TBL] [Abstract][Full Text] [Related]
12. The Canadian Society of Breast Imaging Recommendations for the Management of Axillary Adenopathy in Patients with Recent COVID-19 Vaccination - Update.
Seely JM; Barry MH
Can Assoc Radiol J; 2021 Nov; 72(4):601-602. PubMed ID: 33622040
[No Abstract] [Full Text] [Related]
13. Post-vaccination SARS-CoV-2 axillary adenopathy. Differences with axillary metastases from breast cancer.
Armas-Conde M; Sánchez-Álvarez ÁL; Tejera-Hernández A; Vega-Benítez V; Antela-López JC; Gutiérrez-Giner MI; Hernández-Hernández JR
Cir Cir; 2022; 90(3):410-413. PubMed ID: 35636962
[TBL] [Abstract][Full Text] [Related]
14. Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination.
Horvat JV; Sevilimedu V; Becker AS; Perez-Johnston R; Yeh R; Feigin KN
Eur Radiol; 2022 Aug; 32(8):5752-5758. PubMed ID: 35247087
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management.
McIntosh LJ; Bankier AA; Vijayaraghavan GR; Licho R; Rosen MP
AJR Am J Roentgenol; 2021 Oct; 217(4):975-983. PubMed ID: 33646823
[TBL] [Abstract][Full Text] [Related]
16. Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors.
Lane EG; Eisen CS; Drotman MB; Dodelzon K; Mema E; Thomas C; Prince MR
AJR Am J Roentgenol; 2022 Oct; 219(4):559-568. PubMed ID: 35583425
[No Abstract] [Full Text] [Related]
17. Management Strategies for Patients Presenting With Symptomatic Lymphadenopathy and Breast Edema After Recent COVID-19 Vaccination.
Hao M; Edmonds CE; Nachiappan AC; Conant EF; Zuckerman SP
AJR Am J Roentgenol; 2022 Jun; 218(6):970-976. PubMed ID: 34964358
[TBL] [Abstract][Full Text] [Related]
18. Axillary Lymphadenopathy After a COVID-19 Vaccine Booster Dose: Time to Resolution on Ultrasound Follow-Up and Associated Factors.
Mema E; Lane EG; Drotman MB; Eisen CS; Thomas C; Prince MR; Dodelzon K
AJR Am J Roentgenol; 2023 Aug; 221(2):175-183. PubMed ID: 36883774
[No Abstract] [Full Text] [Related]
19. COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT.
Lane DL; Neelapu SS; Xu G; Weaver O
Korean J Radiol; 2021 Dec; 22(12):1938-1945. PubMed ID: 34719892
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
Raj S; Ogola G; Han J
Acad Radiol; 2022 Apr; 29(4):501-507. PubMed ID: 34906409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
